Literature DB >> 14770291

The complexity of parathyroid hormone-related protein signalling.

E Maioli1, V Fortino.   

Abstract

Our understanding of the mode of action of parathyroid hormone-related protein (PTHrP) has changed profoundly during the last decade. Most PTHrP activities are mediated by membrane receptors through autocrine/paracrine pathways. However, both endogenous and exogenous PTHrP also appear to have intracrine effects through translocation into the nucleus. The present review proposes unconventional PTHrP signalling, based on novel clues. First, PTHrP binding to its membrane receptor triggers internalization of the whole complex, mediated by beta-arrestin. There is growing evidence that the receptor and arrestin are the effectors of biological responses, rather than the ligand (or in addition to the ligand). Second, the existence of putative PTHrP targets within the cytoplasm is beginning to be supported. Recent findings of interactions between a COOH-terminus of PTHrP and beta-arrestin and between the PTHrP receptor and 14-3-3 proteins represent the starting point for identification of intracellular partners of both the hormone and its receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770291     DOI: 10.1007/s00018-003-3233-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  37 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

2.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.

Authors:  M F Newman; J L Kirchner; B Phillips-Bute; V Gaver; H Grocott; R H Jones; D B Mark; J G Reves; J A Blumenthal
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

3.  Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years.

Authors:  Ajay Agarwal; Annapoorna S Kini; Srinivas Attanti; Paul C Lee; Ramin Ashtiani; Angelica M Steinheimer; Pedro R Moreno; Samin K Sharma
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

4.  The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening.

Authors:  John E Cosmi; Smadar Kort; Paul A Tunick; Barry P Rosenzweig; Robin S Freedberg; Edward S Katz; Robert M Applebaum; Itzhak Kronzon
Journal:  Arch Intern Med       Date:  2002-11-11

5.  Percutaneous suture closure for management of large French size arterial puncture in aortic valvuloplasty.

Authors:  L W Solomon; B Fusman; N Jolly; A Kim; T Feldman
Journal:  J Invasive Cardiol       Date:  2001-08       Impact factor: 2.022

6.  Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty.

Authors:  A D Michaels; T A Ports
Journal:  Catheter Cardiovasc Interv       Date:  2001-08       Impact factor: 2.692

Review 7.  [Aortic valve stenosis: from valvuloplasty to percutaneous heart valve].

Authors:  Stefan Sack; Philip Kahlert; Sasan Khandanpour; Igor Kordish; Marco Budeus; Christoph Naber; Sebastian Philipp; Stefan Möhlenkamp; Raimund Erbel
Journal:  Herz       Date:  2006-10       Impact factor: 1.443

8.  Cognitive deficit after aortic valve replacement.

Authors:  Daniel Zimpfer; Martin Czerny; Juliane Kilo; Marie-Theres Kasimir; Christian Madl; Ludwig Kramer; Georg M Wieselthaler; Ernst Wolner; Michael Grimm
Journal:  Ann Thorac Surg       Date:  2002-08       Impact factor: 4.330

9.  Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly.

Authors:  Stefan Sack; Philipp Kahlert; Sasan Khandanpour; Christoph Naber; Sebastian Philipp; Stefan Möhlenkamp; Burkhard Sievers; Hagen Kälsch; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2008-04-03       Impact factor: 5.460

10.  Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.

Authors:  C M Otto; M C Mickel; J W Kennedy; E L Alderman; T M Bashore; P C Block; J A Brinker; D Diver; J Ferguson; D R Holmes
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

View more
  9 in total

1.  PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.

Authors:  Jiarong Li; Andrew C Karaplis; Dao C Huang; Peter M Siegel; Anne Camirand; Xian Fang Yang; William J Muller; Richard Kremer
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

2.  PTHrP promotes colon cancer cell migration and invasion in an integrin α6β4-dependent manner through activation of Rac1.

Authors:  Ramanjaneya V Mula; Vandanajay Bhatia; Miriam Falzon
Journal:  Cancer Lett       Date:  2010-07-15       Impact factor: 8.679

3.  Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival.

Authors:  V Bhatia; M K Saini; M Falzon
Journal:  Regul Pept       Date:  2009-07-17

4.  PTHrP attenuates osteoblast cell death and apoptosis induced by a novel class of anti-cancer agents.

Authors:  Sahiti Chukkapalli; Edi Levi; Arun K Rishi; Nabanita S Datta
Journal:  Endocrine       Date:  2015-08-11       Impact factor: 3.633

5.  EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.

Authors:  Vandanajay Bhatia; Manjit K Saini; Xiaoli Shen; Lian X Bi; Suimin Qiu; Nancy L Weigel; Miriam Falzon
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

6.  Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibody.

Authors:  Anne Camirand; Ibtihal Fadhil; Aimée-Lee Luco; Benoît Ochietti; Richard B Kremer
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

7.  Pthlh, a promising cancer modifier gene in rat tongue carcinogenesis.

Authors:  Hirohiko Suwa; Masato Hirano; Kouji Kawarada; Motohiko Nagayama; Michiko Ehara; Tomonari Muraki; Hayase Shisa; Aiko Sugiyama; Masahiro Sugimoto; Hiroshi Hiai; Motoo Kitano; Jun-Ichi Tanuma
Journal:  Oncol Rep       Date:  2013-11-20       Impact factor: 3.906

8.  Parathyroid Hormone-Related Protein in the Hand or Out of Hand?

Authors:  Sang Wan Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2018-06

9.  PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease.

Authors:  Gloria Assaker; Anne Camirand; Bassam Abdulkarim; Atilla Omeroglu; Jean Deschenes; Kurian Joseph; Abu Shadat Mohammod Noman; Agnihotram V Ramana Kumar; Richard Kremer; Siham Sabri
Journal:  JNCI Cancer Spectr       Date:  2019-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.